{
    "2019-01-04": [
        [
            {
                "time": "",
                "original_text": "断供！有A股药企放弃带量采购，药价太低扛不住成本，招标政策迎来考验",
                "features": {
                    "keywords": [
                        "断供",
                        "A股药企",
                        "带量采购",
                        "药价",
                        "成本",
                        "招标政策"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "日本医疗器械行业深度研究之一:整体篇",
                "features": {
                    "keywords": [
                        "日本",
                        "医疗器械",
                        "行业研究"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}